Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of community-based oral antiviral treatments against severe COVID-19 outcomes in people 70 years and over in Victoria, Australia, 2022: an observational study
Christina Van Heer, S. S. Majumdar, Indra Parta, et al.
The Lancet Regional Health - Western Pacific (2023) Vol. 41, pp. 100917-100917
Open Access | Times Cited: 12

Showing 12 citing articles:

A Tale of Two Drugs: Molnupiravir and Paxlovid
Michael D. Waters, Stafford G. Warren
Mutation Research/Reviews in Mutation Research (2025) Vol. 795, pp. 108533-108533
Closed Access
Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study
Judith Thomas, Abbish Kamalakkannan, Mirela Prgomet, et al.
Australian Journal of Primary Health (2025) Vol. 31, Iss. 1
Closed Access
Cost-effectiveness of nirmatrelvir/ritonavir in COVID-19 patient groups at high risk for progression to severe COVID-19 in the Netherlands
Carlos Duarte, Michel L. Peters, Michelle H. M. de Goeij, et al.
Cost Effectiveness and Resource Allocation (2025) Vol. 23, Iss. 1
Open Access
Effectiveness of nirmatrelvir/ritonavir and molnupiravir in non-hospitalized adults with COVID-19: systematic review and meta-analysis of observational studies
Yonatan Moges Mesfin, Joseph E. Blais, Kelemu Tilahun Kibret, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 9, pp. 2119-2131
Open Access | Times Cited: 4
Nationwide Target Trial Emulation Evaluating the Clinical Effectiveness of Oral Antivirals for COVID-19 in Korea
Kyungmin Huh, Youngji Jo, Gi Hwan Bae, et al.
Journal of Korean Medical Science (2024) Vol. 39, Iss. 42
Open Access | Times Cited: 2
Admission screening testing of patients and staff N95 respirators are cost-effective in reducing COVID-19 hospital-acquired infections
Fenella McAndrew, Romesh Abeysuriya, Rachel Sacks‐Davis, et al.
Journal of Hospital Infection (2024) Vol. 152, pp. 81-92
Closed Access | Times Cited: 2
Admission Screening Testing of Patients and Staff N95 Masks are Cost-Effective in Reducing COVID-19 Hospital Acquired Infections
Fenella McAndrew, Romesh Abeysuriya, Rachel Sacks‐Davis, et al.
(2024)
Closed Access | Times Cited: 1
Physician characteristics associated with antiviral prescriptions for older adults with COVID-19 in Japan: an observational study
Atsushi Miyawaki, K Kitajima, Akihiro Iwata, et al.
BMJ Open (2024) Vol. 14, Iss. 3, pp. e083342-e083342
Open Access | Times Cited: 1
Assessment of pharmacokinetics and tolerability following single‐dose administration of molnupiravir in participants with hepatic or renal impairment
Kelly Duncan, Russ P. Carstens, Kristin L. Butterfield, et al.
Clinical and Translational Science (2024) Vol. 17, Iss. 12
Open Access
The Pivotal Role of Molnupiravir in Protecting High-Risk Populations in the Endemic Era of COVID-19: Insight from Real-World Evidence
Eun‐Jeong Joo
Infection and Chemotherapy (2024) Vol. 56, Iss. 1, pp. 98-98
Open Access
EFFECTS OF ANTIVIRAL THERAPEUTIC DRUGS FOR SARS-COV-2 ON TREATMENT OUTCOMES AND CLINICAL PARAMETERS
Abdul Bari, Atiqullah Sarwari, Mohammad Hassan, et al.
Eurasian Journal of Ecology (2024) Vol. 79, Iss. 2, pp. 136-146
Open Access
Considerations for improving future pandemic responses
Mikolaj Raszek, David E. Cowley, Rubio-Casillas Alberto
Journal of Vaccines and Immunology (2023) Vol. 10, Iss. 1, pp. 001-005
Open Access
Page 1

Scroll to top